Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo‐controlled feasibility study
Open Access
- 5 June 2009
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 39 (7) , 1060-1068
Abstract
Summary: Background Epidemiological evidence suggests that hookworm infection protects against asthma. However, for ethical and safety reasons, before testing this hypothesis in a clinical trial in asthma it is necessary to establish whether experimental hookworm infection might exacerbate airway responsiveness during larval lung migration.Objective To determine whether hookworm larval migration through the lungs increases airway responsiveness in allergic individuals with measurable airway responsiveness but not clinical asthma, and investigate the general tolerability of infection and effect on allergic symptoms.Methods Thirty individuals with allergic rhinoconjunctivitis and measurable airway responsiveness to adenosine monophosphate (AMP) but not clinically diagnosed asthma were randomized, double‐blind to cutaneous administration of either 10 hookworm larvae or histamine placebo, and followed for 12 weeks. The primary outcome was the maximum fall from baseline in provocative dose of inhaled AMP required to reduce 1‐s forced expiratory volume by 10% (PD10AMP) measured at any time over the 4 weeks after active or placebo infection. Secondary outcomes included peak flow variability in the 4 weeks after infection, rhinoconjunctivitis symptom severity and adverse effect diary scores over the 12‐week study period, and change in allergen skin test responses between baseline and 12 weeks.Results Mean maximum change in PD10AMP from baseline was slightly but not significantly greater in the hookworm than the placebo group (−1.67 and −1.16 doubling doses; mean difference −0.51, 95% confidence interval −1.80 to 0.78, P=0.42). Symptom scores of potential adverse effects were more commonly reported in the hookworm group, but infection was generally well tolerated. There were no significant differences in peak‐flow variability, rhinoconjunctivitis symptoms or skin test responses between groups.Conclusion Hookworm infection did not cause clinically significant exacerbation of airway responsiveness and was well tolerated. Suitably powered trials are now indicated to determine the clinical effectiveness of hookworm infection in allergic rhinoconjunctivitis and asthma.Keywords
This publication has 32 references indexed in Scilit:
- Intestinal allergy expels hookworms: seeing is believingTrends in Parasitology, 2006
- Parasite role reversal: worms on trialTrends in Parasitology, 2005
- Comparative cutoff points for adenosine monophosphate and methacholine challenge testingAnnals of Allergy, Asthma & Immunology, 2004
- Use of sequential quadrupling dose regimens to study efficacy of inhaled corticosteroids in asthmaThorax, 2004
- Adenosine monophosphate and histamine induced bronchoconstriction: repeatability and protection by terbutalineThorax, 1997
- The partial characterization of proteases present in the excretory/secretory products and exsheathing fluid of the infective (L3) larva of Necator americanusInternational Journal for Parasitology, 1992
- EOSINOPHILIC ENTERITIS – A RECENT NORTH QUEENSLAND EXPERIENCEAustralian and New Zealand Journal of Medicine, 1988
- Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma.Thorax, 1988
- Non-Specific Potentiation of IgE by Parasitic Infections in ManInternational Archives of Allergy and Immunology, 1979
- IgE, PARASITES, AND ALLERGYThe Lancet, 1976